GCN2 inhibition reduces mutant SOD1 clustering and toxicity and delays disease progression in an amyotrophic lateral sclerosis mouse model

Ortiz, Didio Alberto; Peregrín, Nuria; Valencia, Miguel; Vinueza-Gavilanes, Rodrigo; Marin-Ordovas, Elisa; Ferrero, Roberto

Ver

GCN2 inhibition reduces mutant SOD1 clustering and toxicity and delays disease progression in an amyotrophic lateral sclerosis mouse model, 2024 (951.6Kb)

Autor

Ortiz, Didio Alberto

Peregrín, Nuria

Valencia, Miguel

Vinueza-Gavilanes, Rodrigo

Marin-Ordovas, Elisa

Ferrero, Roberto

Fecha

2024-09-20

Enlace permanente

https://hdl.handle.net/11351/12459

DOI

10.1186/s40035-024-00441-w

ISSN

2047-9158

WOS

001317459900001

PMID

39304897

Registro Completo

Palabras clave

Toxicidad; Modelo de ratón; Esclerosis lateral amiotrófica

Citación recomendada

Ortiz DA, Peregrín N, Valencia M, Vinueza-Gavilanes R, Marín-Ordovas E, Ferrero R, et al. GCN2 inhibition reduces mutant SOD1 clustering and toxicity and delays disease progression in an amyotrophic lateral sclerosis mouse model. Transl Neurodegener. 2024 Sep 20;13:49.